HNN3.0
Register
Register
Register

Project cooperationUpdated on 22 January 2026

Marine compounds and their nutritional and health effects

Researcher at Møreforsking AS

Ålesund, Norway

About

Møreforsking is a research institute located in Ålesund, Norway with a strong focus on marine sciences. The institute has for more than 40 years contributed to sustainable marine resource management, innovation and value creation from marine biomass through research in collaboration with industrial clusters, public sector, as well as national and international research institutions. The Institute performs interdisciplinary research on marine resources covering the full value chain from ocean to consumer. Important research areas include sustainable marine ecosystems, fisheries, aquaculture, marine biology, seafood quality, marine biotechnology and molecular cell biology with emphasis on sustainable utilization of marine resources, applications, and consumer behavior.

Møreforsking has laboratory infrastructure for chemical and molecular analysis, a facility for live marine organisms and a process laboratory. We have analytical capability for quality analysis, physical characterization and proximate chemical composition of marine materials. Our lab has instrumentation for protein/peptide profiling by UPLC and fractionation by FPLC, for purification of bioactive proteins, peptides or carbohydrates. It also includes equipment for molecular biology including DNA sequencing (Oxford Nanopore Technologies). We make use of relevant cell culture models for the evaluation of bioactive effects in health and disease.

Topic

  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

Type

  • Partner seeks Consortium/Coordinator

Organisation

Møreforsking AS

R&D Institution

Ålesund, Norway

Similar opportunities

  • Project cooperation

    Algae-Derived Biopolymers for Health, Nutrition & Bioactive Formulations

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Stefano Todde

    Project Specialist at PMO Partners

    IStanbul, Türkiye

  • Project cooperation

    Grant Advisor

    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Milou Pauw

    Grant advisor at Leiden University Medical Center

    Leiden, Netherlands

  • Project cooperation

    MELIS Collaboration Opportunities

    • Partner seeks Consortium/Coordinator
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults

    Ester Rodriguez

    EU Funding Advisor at Universitat Pompeu Fabra

    Barcelona, Spain